Effects of edible marijuana

Searching for your content... The net proceeds of the offering will be used for general corporate purposes. So, what gives? Broader worries of retail-driven inflation and hawkish Fed speak appears to have been trumped in ACB stock by news of Aurora receiving certification for a medical grade weed production facility in Germany and assisting the company with a German medical cannabis contract awarded in 2019. Aurora Cannabis is a drug manufacturers-specialty generic business based in the US. Aurora Cannabis stocks ACB.US are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.02 – a decrease of 3.75% over the previous week. Aurora Cannabis employs 1,338 staff and has a trailing 12-month revenue of around $210.5 vancouver medical marijuana clinic million. Management, in an effort to support growth, announced that it will acquire TerraFarma for $38 million. This will give ACB control of TerraFarmarsquo;s lucrative Thrive Cannabis brand. The deal is should close by the end of fiscal 2022. The transaction will strengthen the companyrsquo;s capabilities in the Canadian markets and provide access to TerraFarmarsquo;s award-winning innovative premium products. These include dried flower, pre-rolls, vapor products and concentrates.